Anne McLeer-Florin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Invasive mucinous lung adenocarcinoma (IMA) is a rare subtype of lung adenocarcinoma with no effective treatment option in advanced disease. KRAS mutations occur in 28-87% of the cases. NRG1 fusions were recently discovered in KRAS-negative IMA cases and otherwise negative for known driver oncogenes and could represent an attractive therapeutic target.(More)
  • 1